Childhood obesity is associated with a significant increased risk for several metabolic and cardiovascular complications, including hypertension. The main mechanisms implicated in the pathogenesis of high blood pressure in relation to increased body weight are insulin resistance/hyperinsulinemia, sympathetic nervous system hyperactivity and alterations in vascular structure and function. Obesity-related hypertension is associated with cardiovascular complications already during childhood and with an increased risk of coronary heart disease in adulthood. A high prevalence of the nondipping phenomenon has also been detected in obese children and adolescents and this is worrying as this condition is associated with end-organ damage. Assessing blood pressure is therefore particularly important in obese children and adolescents for an early detection of its alterations. Ambulatory blood pressure monitoring represents an important method of measuring blood pressure, particularly in the suspicion of white-coat hypertension, masked hypertension and non-dipping phenomenon. Prevention and treatment of childhood obesity represent important means in order to prevent and reduce the incidence of hypertension and the associated cardiovascular risk. Reduction in body weight is generally the first step in the management of obesity-related hypertension. However, in severe cases or in cases non responsive to lifestyle interventions, drug therapy should be considered.
Keywords: Hypertension, blood pressure, obesity, children, cardiovascular disease, complications
Smoking and Hypertension: Independent or Additive Effects to Determining Vascular Damage?
Current Vascular Pharmacology Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?
Current Vascular Pharmacology In Vitro and In Vivo Assessment of Matrix Type Transdermal Therapeutic System of Labetalol Hydrochloride
Current Drug Delivery Aliskiren: A New Drug for an Old Problem
Cardiovascular & Hematological Agents in Medicinal Chemistry Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Calcific Aortic Stenosis: Molecular and Cellular Mechanisms, Medical Treatment Alternatives
Current Cardiology Reviews Clinical Importance of Assessment of Type 2 Diabetes Mellitus with Visceral Obesity. A Japanese Perspective
Current Diabetes Reviews Targeting the Liver in the Metabolic Syndrome: Evidence from Animal Models
Current Pharmaceutical Design Endothelial Changes in Individuals with Prehypertension
Current Hypertension Reviews The Effects of Direct Renin Inhibitor, Aliskiren, on Arterial Hypertension, Chronic Kidney Disease and Cardiovascular Disease: Optimal Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Hypertensive Left Ventricular Hypertrophy Regression: Does It Matter?
Current Hypertension Reviews MRI Abnormalities Associated with Mild Cognitive Impairments of Vascular (VMCI) Versus Neurodegenerative (NMCI) Types Prodromal for Vascular and Alzheimers Dementias
Current Alzheimer Research Radicals, Oxidative/Nitrosative Stress and Preeclampsia
Mini-Reviews in Medicinal Chemistry Molecular Mechanisms of Mineralocorticoid Receptor Antagonism by Eplerenone
Mini-Reviews in Medicinal Chemistry Treatment of Hypertension Induced Target Organ Damage in Children and Adolescents
Current Pharmaceutical Design Obstructive Sleep Apnea and Atrial Arrhythmogenesis
Current Cardiology Reviews Cerebrovascular Complications of Diabetes: Focus on Stroke
Endocrine, Metabolic & Immune Disorders - Drug Targets Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
Current Diabetes Reviews Adipose Tissue as a Regulator of Energy Balance
Current Drug Targets Role of the Autonomic Nervous System in the Endothelial Dysfunction of the Metabolic Syndrome
Current Hypertension Reviews